Mayflower Financial Advisors, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 248 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.

Quarter-by-quarter ownership
Mayflower Financial Advisors, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2023$430,834
+40.2%
6,817
-0.2%
0.06%
+40.0%
Q1 2023$307,237
+3.1%
6,829
+0.4%
0.04%
-2.4%
Q4 2022$298,083
-33.6%
6,804
-0.1%
0.04%
-43.1%
Q3 2022$449,000
+30.5%
6,813
+0.1%
0.07%
+35.8%
Q2 2022$344,000
-25.2%
6,806
-5.5%
0.05%
-14.5%
Q1 2022$460,000
-40.3%
7,1990.0%0.06%
-39.2%
Q4 2021$771,000
+4.5%
7,1990.0%0.10%
+2.0%
Q3 2021$738,0007,1990.10%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 645,539$69,144,0007.84%
DAFNA Capital Management LLC 206,911$22,162,0005.57%
Eagle Health Investments LP 192,639$20,634,0005.03%
Casdin Capital, LLC 1,550,000$166,021,0004.68%
CADIAN CAPITAL MANAGEMENT, LP 450,657$48,270,0002.65%
Avidity Partners Management LP 995,000$106,574,0002.26%
Integral Health Asset Management, LLC 75,000$8,033,0002.22%
Rock Springs Capital Management LP 859,755$92,088,0002.13%
Boxer Capital, LLC 507,374$54,345,0002.11%
EFG Asset Management (North America) Corp. 112,715$12,082,0001.58%
View complete list of BLUEPRINT MEDICINES CORP shareholders